BSE filing, NSE: KILITCH. Summary written from the filing by ALFA Finder's alert engine.
Kilitch Drugs(I) Ltd: key numbers
- Share price
- ₹201.32
- Market cap
- ₹703.9 Cr
- Revenue (annual)
- ₹235.5 Cr
- Net profit (annual)
- ₹30.17 Cr
- P/E (TTM)
- 23.4×Sector 45.9×
- Promoter holding
- 63.77%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kilitch Drugs(I) Ltd
All →Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs' EGM notice seeks shareholder approval for selling its Ethiopian material subsidiary and converting subsidiary debt into equity. It also proposes two independent director appointments.
Kilitch Drugs(I) Merger & Restructuring Worth ₹131.6 Cr
Kilitch Drugs will divest its entire Ethiopian subsidiary stake to HarmeeCare for US$14 million (~₹131.6 Crore). Proceeds will fund debt repayment and Pen plant expansion.
- Value
- ₹131.6 Cr
Kilitch Drugs(I) Merger & Restructuring Worth ₹120.8 Cr
Kilitch Drugs will divest its 100% stake in subsidiary Kilitch Estro Biotech PLC for USD 12.855 million (approx. ₹120.84 Crore).
- Value
- ₹120.8 Cr
- From
- HarmeeCare Pharmaceuticals
Kilitch Drugs(I) Management Change
Kilitch Drugs' Non-Executive Independent Director Mr. Venkita Subramanian Rajan resigned effective 21 Oct 2026. He also stepped down from the Audit, NCR, and SRC Committees citing personal commitments.
Kilitch Drugs(I) Other Announcement
Kilitch Drugs (India) Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs (India) held its 34th Annual General Meeting on August 27, 2026, transacting four business resolutions including financial statement approval and director re-appointment.
Other board meeting date announcements
All →Inducto Steel Board Meeting Date
Inducto Steel meets 6 November 2026 to consider unaudited standalone and consolidated Q2 results. This is an advance notice; no decisions yet.
Starlog Enterprises Board Meeting Date
Starlog Enterprises intimated a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting date is proposed, so the results are not yet approved.
KBS India Board Meeting Date
KBS India Limited gave notice of a board meeting on 06 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. Trading window stays closed until 48 hours after results are announced.
iStreet Network Board Meeting Date
iStreet Network meets 6 November 2026 to consider unaudited Q2 results and a possible interim dividend. Trading window closes from 1 October 2026.
Pyramid Technoplast Board Meeting Date
Pyramid Technoplast announced a board meeting on 6 November 2026 to consider unaudited September quarter results. Trading window closes from 1 October 2026.
Visaman Global Sales Board Meeting Date
Visaman Global Sales schedules a 13 November 2026 board meeting to consider half-yearly unaudited results. The trading window stays closed until 15 November 2026.